Bionomics has announced plans to meet with the US Food & Drug Administration (FDA) in Q2 2024 following the release of positive topline data from a Phase IIb trial of its lead candidate BNC210 to ...

The Florida Entomologist, Vol. 64, No. 4 (Dec., 1981), pp. 491-506 (16 pages) Aquatic stages of the mosquito Wyeomyia vanduzeei Dyar & Knab inhabit leaf axils of the epiphytic bromeliad Tillandsia ...

Wieser, W., and Hopper, B. E., Bull. Mus. Comp. Zool. (in the press). Meyers, S. P., and Hopper, B. E., Bull. Mar. Sci., 16 (1966) (in the press).

Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to ...